← All indications
Gastrointestinal Hemorrhage
Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
Subtype terms (3)
More specific conditions that are subtypes of Gastrointestinal Hemorrhage in the MeSH hierarchy.
- Hematemesis
6 drugs (5 approved, 1 experimental)
- Melena
3 drugs approved
- Peptic Ulcer Hemorrhage
9 drugs (8 approved, 1 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (11)
Phase 3 trials (10)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (32)
- Eisai
- Il-Yang Pharm. Co., Ltd.
- Vifor Inc.
- Aarhus University
- Centre of Postgraduate Medical Education
- Changhai Hospital
- Changhua Christian Hospital
- Kaohsiung Medical University
- Kocaeli University
- Medical University of Bialystok
- Medical University of Warsaw
- Ohio State University
- Stanford University
- University of Florida
- University of Virginia
- Chinese University of Hong Kong
- Far Eastern Memorial Hospital
- Scandinavian Critical Care Trials Group
- Taipei Medical University
- Tel Aviv University
- University of British Columbia
- University of Copenhagen
- Medical University of South Carolina
- City University of Hong Kong
- Jiao Tong University
- University of Sao Paulo
- University of Barcelona
- Hallym University
- University of Paris
- Maria Sklodowska Curie Children's Hospital
- +2 more
Organization Involved with Phase 3 Indications (30)
- Celgene
- Bausch Health Companies
- AstraZeneca
- Maastricht University
- Canadian Critical Care Trials Group
- Casa Sollievo della Sofferenza IRCCS
- University of London
- Jeroen Bosch Ziekenhuis
- McMaster University
- Radboud University
- Reinier de Graaf Groep
- Seoul National University
- Tanta University
- University of Rochester
- Aga Khan University
- Chonbuk National University
- Free University of Amsterdam
- University of Western Brittany
- St. Antonius Hospital, Nieuwegein
- Universidad Autonoma de Barcelona
- Casa Sollievo della Sofferenza, San Giovanni Rotondo
- National Health and Medical Research Council, Australia
- Canadian Institutes of Health Research (CIHR)
- Australian and New Zealand Intensive Care Society Clinical Trials Group
- Elisabeth-TweeSteden Ziekenhuis
- Gelre Hospitals
- Bernhoven
- Rouen Normandy University
- Government of France
- Government of Spain
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (26)
- Abbott
- The Gerber Foundation
- Harvard University
- D'Annunzio University of Chieti–Pescara
- McGill University
- Shandong Provincial Hospital
- Texas Tech University
- University of Louisville
- University of Oklahoma
- University of South Carolina
- Wuhan University
- Capital Medical University
- Fudan University
- Institute of Liver and Biliary Sciences, India
- Soochow University
- Anhui College of Traditional Chinese Medicine
- University of Haifa
- University of Indonesia
- University of Missouri
- Hebrew University
- The University of Hong Kong
- Technion University
- Ben Gurion University
- Second People's Hospital of Lanzhou
- American Society for Gastrointestinal Endoscopy
- Blymum Srl